Jpmorgan Chase & CO Ocugen, Inc. Transaction History

Jpmorgan Chase & CO

$1.14 Trillion
Q2 2024

A detailed history of Jpmorgan Chase & CO transactions in Ocugen, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 109,248 shares of OCGN stock, worth $104,878. This represents 0.0% of its overall portfolio holdings.

Number of Shares

109,248

Previous 391,925 72.13%

Holding current value

$104,878

Previous $642,000 73.68%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$1.18 - $1.98 $333,558 - $559,700	-282,677 Reduced 72.13%	109,248 $169,000
Q1 2024 May 10, 2024	BUY	$0.5 - $1.83 $104,556 - $382,674	209,112 Added 114.39%	391,925 $642,000
Q4 2023 Feb 12, 2024	BUY	$0.36 - $0.57 $17,400 - $27,551	48,336 Added 35.94%	182,813 $104,000
Q3 2023 Nov 14, 2023	SELL	$0.4 - $0.62 $1.16 Million - $1.8 Million	-2,905,579 Reduced 95.58%	134,477 $53,000
Q2 2023 Aug 11, 2023	SELL	$0.45 - $0.88 $45,675 - $89,320	-101,501 Reduced 3.23%	3,040,056 $1.64 Million
Q1 2023 May 18, 2023	BUY	$0.82 - $1.33 $136,466 - $221,341	166,422 Added 5.59%	3,141,557 $2.67 Million
Q1 2023 May 11, 2023	SELL	$0.82 - $1.33 $649,221 - $1.05 Million	-791,733 Reduced 21.02%	2,975,135 $2.53 Million
Q4 2022 Feb 13, 2023	BUY	$1.11 - $1.87 $704,497 - $1.19 Million	634,682 Added 20.26%	3,766,868 $4.9 Million
Q3 2022 Nov 14, 2022	SELL	$1.75 - $3.1 $283,643 - $502,454	-162,082 Reduced 4.92%	3,132,186 $5.58 Million
Q2 2022 Aug 11, 2022	SELL	$1.83 - $3.45 $1.32 Million - $2.49 Million	-721,474 Reduced 17.97%	3,294,268 $7.48 Million
Q1 2022 May 11, 2022	BUY	$2.34 - $4.72 $1.62 Million - $3.27 Million	693,786 Added 20.88%	4,015,742 $13.3 Million
Q4 2021 Feb 10, 2022	BUY	$4.38 - $15.67 $12.1 Million - $43.3 Million	2,762,832 Added 494.14%	3,321,956 $15.1 Million
Q3 2021 Nov 12, 2021	BUY	$6.36 - $8.51 $3.56 Million - $4.76 Million	559,124 New	559,124 $4.01 Million

Others Institutions Holding OCGN

# of Institutions

109

Shares Held

66.7M

Call Options Held

516K

Put Options Held

272K

View Full List

About Ocugen, Inc.

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $208M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

More about OCGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Ocugen, Inc. Transaction History